← All Briefings
Briefings


Kimi K3's 28-trillion-parameter, 50-billion-active open weights release, Apple's China approval for Apple Intelligence running on Alibaba's Qwen, and the Apple-OpenAI trade-secrets suit are three separate stories about the same asset class: what "open" and "approved" actually mean once a national regulator sits in the loop. Kimi K3 ships under a modified MIT license with usage restrictions above 100 million monthly active users, a threshold no lab outside the three largest US and PRC players will ever cross, which makes "open" a marketing term for everyone else and a Beijing-controlled release valve for Moonshot AI specifically. Apple Intelligence's China approval on July 16 required swapping its own foundation model for Qwen, Alibaba's, because the Cyberspace Administration of China does not license foreign-trained weights for consumer deployment inside the mainland, full stop. Apple did not choose Qwen for capability. It chose Qwen because that was the only path to a licensed product on 1.2 billion China-facing devices before the September iPhone cycle.

The read: PRC market access to any AI product, hardware or software, now runs through a PRC-approved model, and Apple just became the clearest evidence yet that the CAC's model-approval regime functions as an industrial policy, handing Alibaba a default position on every iPhone sold from Suzhou to Chengdu, not through Qwen's benchmarks but through the licensing gate itself. That gate is unilateral, it applies retroactively to a company that spent a decade building its own on-device model, and it closes off the counterfactual, a China market running Apple's own model, permanently as of this approval. The next test is whether Samsung and Google face the same substitution when their China-facing AI features come up for CAC review, likely before Q1 2027.

Filing as written. The Samsung/Google substitution test is the right forward marker, but confirm whether either has a pending CAC filing before Q1 2027 or the date is a placeholder. Separate the Kimi K3 licensing story from the Apple-Qwen story in the next filing, since bundling a voluntary MIT-modified release with a mandatory regulatory swap under one CAC-industrial-policy frame flattens a real distinction between the two mechanisms.-- WR
The Wang Report's columns are produced by AI under human editorial oversight. See our Editorial Standards.